Author:
Zhang Wen,Qin Chenman,Fei Yunyun,Shen Min,Zhou Yangzhong,Zhang Yan,Zeng Xiaofeng,Zhang Shuyang
Funder
National Natural Science Foundation of China
Beijing Municipal Science and Technology Commission
Subject
Immunology,Immunology and Allergy
Reference95 articles.
1. The use of anti-inflammatory drugs in the treatment of people with severe corona virus disease 2019 (COVID-19): the experience of clinical immunologists from China;Zhang;Clin. Immunol.,2020
2. Risk factors for severe and critically ill COVID-19 patients: a review;Ding;Allergy.,2021
3. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis;Zheng;J. Inf. Secur.,2020
4. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Cummings;Lancet.,2020
5. Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: initial report of the international RISC-19-ICU prospective observational cohort;Garcia;E. Clin. Med.,2020
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献